<DOC>
	<DOCNO>NCT02988869</DOCNO>
	<brief_summary>The overall objective ass bronchodilator effect daily Tiotropium/Formoterol combination deliver via Discair® compare Tiotropium ( q.d . ) monotherapy deliver via Handihaler tiotropium ( q.d . ) deliver via Handihaler + formoterol ( b.i.d ) deliver via Aerolizer free combination treatment patient stable moderate severe COPD . Spirometric measurement ( FEV1 , FVC ) perform period 24 h 12 different time : pre-treatment ( 15 min prior first dose ) post-treatment ( 30. min , 60 min [ 1 hr ] , 120 min [ 2 hr ] , 180 min [ 3 hr ] , 240 min [ 4 hr ] , 360 min [ 6 hr ] , 480 min [ 8 hr ] , 600 min [ 10 hr ] , 720 min [ 12 hr ] , 840 min [ 14 hr ] ,1440 min [ 24 hr ] .</brief_summary>
	<brief_title>Tiotropium/Formoterol Via Discair® v Tiotropium Monotherapy Tiotropium + Formoterol Free Combination Treatment</brief_title>
	<detailed_description>The overall objective ass bronchodilator effect daily Tiotropium/Formoterol combination deliver via Discair® compare Tiotropium ( q.d . ) monotherapy deliver via Handihaler tiotropium ( q.d . ) deliver via Handihaler + formoterol ( b.i.d ) deliver via Aerolizer free combination treatment patient stable moderate severe COPD . Patients randomly assign receive Tiotropium/Formoterol combination dry powder inhalation Discair® ( test inhaler , n = 29 ) Tiotropium dry powder capsule inhalation HandiHaler tiotropium dry powder capsule inhalation HandiHaler + formoterol dry powder capsule inhalation Aerolizer . Patients evaluate 4 consecutive visit : baseline ( enrollment ) , screen , treatment , 24h treatment . For newly diagnose formerly diagnosed patient COPD medication , screen visit perform day enrollment . For formerly diagnose patient receive COPD treatment , day screen visit base completion run-in period , length determine specific medication . During run-in period , salbutamol ( 100 µg inhaler ) prescribe rescue medication . Spirometric measurement ( FEV1 , FVC ) perform period 24 h 12 different time : pre-treatment ( 15 min prior first dose ) post-treatment ( 30. min , 60 min [ 1 hr ] , 120 min [ 2 hr ] , 180 min [ 3 hr ] , 240 min [ 4 hr ] , 360 min [ 6 hr ] , 480 min [ 8 hr ] , 600 min [ 10 hr ] , 720 min [ 12 hr ] , 840 min [ 14 hr ] ,1440 min [ 24 hr ] .</detailed_description>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<criteria>Patients age ≥40 year COPD diagnosis accord current GOLD ( The Global Initiative Chronic Obstructive Lung Disease ) strategy . Patients symptomatic stable moderate severe COPD diagnosis postbronchodilator FEV1/FVC ratio &lt; 0.70 , FEV1 &lt; 80 % predict normal screening visit . Current smoker exsmokers smoke history least 10 packyears Patients exacerbation within last 4 week Females patient childbearing potential use effective birth control method Patients sign write informed consent prior participation Patients accept comply requirement protocol Patients capability communicate investigator History hypersensitivity drug contain anticholinergic , betaadrenergic , lactose Diagnosis asthma Patients vaccinate live attenuate vaccine within 2 week prior screen visit runin period . Patients COPD exacerbation lower respiratory track infection require antibiotic , oral parenteral corticosteroid treatment within 4 week prior screen visit runin period . Patients history myocardial infarction , hearth failure , acute ischemic coroner disease severe cardiac arrhythmia require treatment within least 6 week Patients lung cancer Patients active tuberculosis Patients use oxygen therapy Patients common interstitial lung disease like cystic fibrosis , bronchiolitis obliterans Patients serious liver renal disease lead organ failure Women pregnant nursing History allergic rhinitis atopy Known symptomatic prostatic hypertrophy require drug therapy operation Patients narrowangle glaucoma require drug therapy</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>COPD</keyword>
	<keyword>Tiotropium</keyword>
	<keyword>Formoterol</keyword>
</DOC>